Centene is a dominant, diversified insurer with strong positions in Medicaid, ACA, and Medicare Part D, serving nearly 29 million members. Q1 2025 results exceeded expectations, with robust revenue growth, improved margins, and management raising full-year revenue guidance. Valuation models indicate a fair value of $60 per share, offering 9% upside; downside risk is limited, and FCF assumptions are conservative.
SACRAMENTO, Calif. , June 2, 2025 /PRNewswire/ -- Following Gov.
STNE, CNC, CVS and PFE stand out as top value picks amid trade tensions and a murky H2 economic outlook.
Alongside housing, individuals receive primary care, mental health and substance use support, employment guidance and more personal services to help rebuild their lives SACRAMENTO, Calif. , June 3, 2025 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC), awarded a $2.6 million grant to connect individuals exiting the criminal justice system in Sacramento County to services that support a successful reentry into the community.
Preventative services, social support, health education and more to improve care access, quality and outcomes SACRAMENTO, Calif. , May 29, 2025 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans, and the Centene Foundation, the philanthropic arm of Centene Corporation (NYSE: CNC), today announced a partnership investment of more than $7.2 million to expand healthcare services to underserved Californians through mobile health clinics.
The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, PFE, STNE and PSFE are some such stocks.
The funding is made available through an annual program that addresses barriers to healthcare. AUSTIN, Texas , May 29, 2025 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene (NYSE: CNC), has announced the latest recipients of its annual community and provider grant program.
Centene offers strong revenue and earnings growth, coupled with a large national membership base and attractive valuation. Despite these positives, the stock has underperformed in recent years, prompting further investigation. The primary issue is CNC's persistent struggle to meet average industry quality measures in its health plans.
CNC remains well-poised for growth on improved premiums, a well-performing Commercial Marketplace business, strategic divestitures and sound cash reserves.
The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, PFE, STNE and SAN are some such stocks.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.